| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obsessive-Compulsive Disorder | 312 | 2025 | 831 | 59.580 |
Why?
|
| Anxiety Disorders | 118 | 2025 | 734 | 23.930 |
Why?
|
| Anxiety | 128 | 2025 | 1002 | 17.540 |
Why?
|
| Parents | 87 | 2025 | 1076 | 12.470 |
Why?
|
| Psychiatric Status Rating Scales | 93 | 2025 | 855 | 12.080 |
Why?
|
| Implosive Therapy | 29 | 2025 | 98 | 10.830 |
Why?
|
| Autism Spectrum Disorder | 34 | 2025 | 430 | 10.030 |
Why?
|
| Adolescent | 373 | 2025 | 20553 | 9.120 |
Why?
|
| Depression | 83 | 2025 | 1351 | 8.910 |
Why?
|
| Psychometrics | 76 | 2025 | 693 | 8.240 |
Why?
|
| Child | 360 | 2025 | 25827 | 7.750 |
Why?
|
| Autistic Disorder | 22 | 2025 | 387 | 7.420 |
Why?
|
| Stress Disorders, Post-Traumatic | 24 | 2025 | 651 | 6.130 |
Why?
|
| Humans | 600 | 2025 | 132348 | 5.950 |
Why?
|
| Severity of Illness Index | 96 | 2025 | 3087 | 5.450 |
Why?
|
| Mental Disorders | 26 | 2025 | 893 | 5.240 |
Why?
|
| Male | 371 | 2025 | 65061 | 5.200 |
Why?
|
| Family | 25 | 2025 | 595 | 5.070 |
Why?
|
| Tourette Syndrome | 24 | 2023 | 158 | 5.060 |
Why?
|
| Treatment Outcome | 140 | 2025 | 13017 | 5.060 |
Why?
|
| Female | 373 | 2025 | 70795 | 4.960 |
Why?
|
| Behavior Therapy | 21 | 2021 | 269 | 4.760 |
Why?
|
| Surveys and Questionnaires | 92 | 2025 | 3980 | 4.720 |
Why?
|
| Tic Disorders | 23 | 2020 | 78 | 4.470 |
Why?
|
| Suicidal Ideation | 15 | 2025 | 254 | 4.410 |
Why?
|
| Deep Brain Stimulation | 22 | 2025 | 431 | 4.290 |
Why?
|
| Adaptation, Psychological | 31 | 2025 | 455 | 3.970 |
Why?
|
| Compulsive Behavior | 17 | 2023 | 41 | 3.940 |
Why?
|
| Self Report | 25 | 2024 | 552 | 3.850 |
Why?
|
| Family Relations | 13 | 2025 | 71 | 3.780 |
Why?
|
| Trichotillomania | 14 | 2019 | 34 | 3.770 |
Why?
|
| Comorbidity | 55 | 2025 | 1605 | 3.660 |
Why?
|
| Obsessive Behavior | 14 | 2019 | 19 | 3.530 |
Why?
|
| Adult | 160 | 2025 | 31619 | 3.490 |
Why?
|
| Phobic Disorders | 12 | 2020 | 43 | 3.480 |
Why?
|
| Family Therapy | 12 | 2020 | 35 | 3.460 |
Why?
|
| Fear | 14 | 2025 | 205 | 3.450 |
Why?
|
| Suicide | 12 | 2025 | 203 | 3.370 |
Why?
|
| Reproducibility of Results | 68 | 2025 | 3023 | 3.370 |
Why?
|
| Cycloserine | 14 | 2022 | 23 | 3.290 |
Why?
|
| Quality of Life | 28 | 2024 | 2151 | 3.250 |
Why?
|
| Child Development Disorders, Pervasive | 11 | 2016 | 82 | 3.010 |
Why?
|
| Depressive Disorder | 17 | 2025 | 481 | 3.010 |
Why?
|
| Antipsychotic Agents | 15 | 2024 | 380 | 2.990 |
Why?
|
| Osteogenesis Imperfecta | 4 | 2025 | 168 | 2.940 |
Why?
|
| Peer Group | 18 | 2025 | 121 | 2.940 |
Why?
|
| Students | 17 | 2020 | 263 | 2.850 |
Why?
|
| Young Adult | 74 | 2025 | 9945 | 2.810 |
Why?
|
| Psychotherapy | 10 | 2025 | 247 | 2.800 |
Why?
|
| Combined Modality Therapy | 36 | 2024 | 1297 | 2.690 |
Why?
|
| Emotions | 16 | 2024 | 367 | 2.580 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 17 | 2025 | 236 | 2.490 |
Why?
|
| Depressive Disorder, Major | 14 | 2025 | 461 | 2.480 |
Why?
|
| Parent-Child Relations | 19 | 2025 | 253 | 2.420 |
Why?
|
| Psychotropic Drugs | 10 | 2022 | 129 | 2.320 |
Why?
|
| Extinction, Psychological | 7 | 2025 | 26 | 2.210 |
Why?
|
| Transcranial Magnetic Stimulation | 8 | 2024 | 80 | 2.190 |
Why?
|
| Hearing Disorders | 5 | 2024 | 29 | 2.160 |
Why?
|
| Telemedicine | 7 | 2024 | 506 | 2.130 |
Why?
|
| Antidepressive Agents | 11 | 2025 | 327 | 2.110 |
Why?
|
| Caregivers | 13 | 2025 | 598 | 2.070 |
Why?
|
| Attitude of Health Personnel | 9 | 2024 | 722 | 2.060 |
Why?
|
| Cyclonic Storms | 5 | 2022 | 79 | 1.920 |
Why?
|
| Therapy, Computer-Assisted | 5 | 2023 | 24 | 1.910 |
Why?
|
| Pandemics | 11 | 2022 | 1188 | 1.910 |
Why?
|
| Factor Analysis, Statistical | 28 | 2025 | 235 | 1.890 |
Why?
|
| Resilience, Psychological | 4 | 2025 | 78 | 1.870 |
Why?
|
| Loneliness | 15 | 2017 | 34 | 1.830 |
Why?
|
| Hoarding Disorder | 5 | 2016 | 7 | 1.810 |
Why?
|
| Mental Health | 10 | 2025 | 377 | 1.800 |
Why?
|
| Social Adjustment | 9 | 2018 | 79 | 1.750 |
Why?
|
| Aggression | 10 | 2016 | 230 | 1.720 |
Why?
|
| Middle Aged | 70 | 2025 | 28891 | 1.660 |
Why?
|
| Attitude | 8 | 2021 | 120 | 1.650 |
Why?
|
| Adolescent Behavior | 10 | 2019 | 171 | 1.650 |
Why?
|
| Cognition | 20 | 2024 | 814 | 1.590 |
Why?
|
| Interview, Psychological | 8 | 2024 | 108 | 1.590 |
Why?
|
| Social Justice | 2 | 2024 | 65 | 1.580 |
Why?
|
| Hoarding | 6 | 2022 | 7 | 1.510 |
Why?
|
| Crime Victims | 10 | 2010 | 70 | 1.500 |
Why?
|
| Anger | 3 | 2022 | 30 | 1.490 |
Why?
|
| Streptococcal Infections | 8 | 2024 | 248 | 1.490 |
Why?
|
| Qualitative Research | 7 | 2025 | 664 | 1.480 |
Why?
|
| Personality Inventory | 18 | 2021 | 179 | 1.470 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 14 | 2024 | 229 | 1.420 |
Why?
|
| Behavioral Symptoms | 5 | 2020 | 25 | 1.400 |
Why?
|
| Psychological Tests | 6 | 2007 | 94 | 1.400 |
Why?
|
| Signal Detection, Psychological | 5 | 2016 | 10 | 1.390 |
Why?
|
| Awareness | 6 | 2018 | 80 | 1.390 |
Why?
|
| Auditory Perceptual Disorders | 3 | 2015 | 5 | 1.370 |
Why?
|
| Rage | 3 | 2015 | 6 | 1.340 |
Why?
|
| Suicide, Attempted | 4 | 2025 | 154 | 1.340 |
Why?
|
| Sertraline | 7 | 2019 | 45 | 1.330 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 7 | 2015 | 45 | 1.320 |
Why?
|
| Psychiatry | 5 | 2024 | 271 | 1.270 |
Why?
|
| Child, Preschool | 46 | 2024 | 14857 | 1.260 |
Why?
|
| China | 10 | 2023 | 290 | 1.260 |
Why?
|
| Child Behavior | 9 | 2017 | 236 | 1.260 |
Why?
|
| Ketamine | 3 | 2022 | 225 | 1.250 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2020 | 478 | 1.240 |
Why?
|
| Coronavirus Infections | 5 | 2020 | 379 | 1.240 |
Why?
|
| Pneumonia, Viral | 5 | 2020 | 390 | 1.240 |
Why?
|
| Patient Preference | 2 | 2024 | 135 | 1.200 |
Why?
|
| Executive Function | 5 | 2020 | 127 | 1.200 |
Why?
|
| Child Behavior Disorders | 9 | 2023 | 70 | 1.170 |
Why?
|
| Temperament | 4 | 2021 | 32 | 1.160 |
Why?
|
| Autoimmune Diseases | 6 | 2024 | 273 | 1.120 |
Why?
|
| Pregnancy Complications | 5 | 2025 | 554 | 1.120 |
Why?
|
| Evidence-Based Medicine | 5 | 2024 | 672 | 1.110 |
Why?
|
| Health Personnel | 3 | 2024 | 546 | 1.090 |
Why?
|
| Health Services Accessibility | 4 | 2024 | 656 | 1.080 |
Why?
|
| Texas | 18 | 2025 | 3629 | 1.050 |
Why?
|
| Life Change Events | 4 | 2015 | 65 | 1.040 |
Why?
|
| Life Expectancy | 3 | 2022 | 59 | 1.040 |
Why?
|
| Evidence-Based Practice | 2 | 2024 | 115 | 1.020 |
Why?
|
| Sound | 3 | 2017 | 22 | 1.020 |
Why?
|
| Internet | 7 | 2024 | 404 | 1.020 |
Why?
|
| Personality Assessment | 10 | 2021 | 111 | 1.020 |
Why?
|
| Periodicals as Topic | 2 | 2020 | 194 | 1.010 |
Why?
|
| Psychological Trauma | 2 | 2024 | 24 | 1.010 |
Why?
|
| Family Health | 7 | 2019 | 257 | 1.010 |
Why?
|
| Phobia, Social | 3 | 2021 | 7 | 1.000 |
Why?
|
| Interpersonal Relations | 10 | 2018 | 233 | 0.990 |
Why?
|
| Chronic Pain | 3 | 2024 | 148 | 0.990 |
Why?
|
| Anti-Anxiety Agents | 5 | 2018 | 77 | 0.980 |
Why?
|
| Social Behavior | 8 | 2008 | 225 | 0.980 |
Why?
|
| Self-Injurious Behavior | 3 | 2017 | 66 | 0.970 |
Why?
|
| Sleep Wake Disorders | 2 | 2024 | 194 | 0.940 |
Why?
|
| Aged | 39 | 2025 | 21381 | 0.930 |
Why?
|
| Reward | 2 | 2025 | 116 | 0.920 |
Why?
|
| Parenting | 8 | 2023 | 349 | 0.910 |
Why?
|
| Affective Symptoms | 1 | 2025 | 63 | 0.910 |
Why?
|
| Cross-Sectional Studies | 21 | 2025 | 3745 | 0.910 |
Why?
|
| Hyperacusis | 2 | 2022 | 4 | 0.900 |
Why?
|
| Anxiety, Separation | 5 | 2017 | 6 | 0.890 |
Why?
|
| Siblings | 3 | 2023 | 202 | 0.890 |
Why?
|
| Consumer Health Information | 1 | 2025 | 29 | 0.890 |
Why?
|
| Diabetes Mellitus, Type 1 | 16 | 2011 | 869 | 0.890 |
Why?
|
| Radiosurgery | 2 | 2023 | 147 | 0.880 |
Why?
|
| Mental Health Services | 5 | 2024 | 281 | 0.880 |
Why?
|
| Child Psychiatry | 5 | 2024 | 16 | 0.870 |
Why?
|
| Vomiting | 2 | 2017 | 108 | 0.870 |
Why?
|
| Electronic Mail | 1 | 2024 | 43 | 0.870 |
Why?
|
| United States | 29 | 2025 | 11628 | 0.870 |
Why?
|
| Interviews as Topic | 8 | 2025 | 426 | 0.870 |
Why?
|
| Stress, Psychological | 9 | 2023 | 577 | 0.860 |
Why?
|
| Mood Disorders | 3 | 2021 | 129 | 0.850 |
Why?
|
| Metacognition | 2 | 2020 | 4 | 0.840 |
Why?
|
| Skin | 4 | 2016 | 540 | 0.840 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 989 | 0.830 |
Why?
|
| Acceptance and Commitment Therapy | 1 | 2024 | 44 | 0.820 |
Why?
|
| Pediatric Nursing | 3 | 2013 | 25 | 0.820 |
Why?
|
| Age Factors | 18 | 2024 | 2931 | 0.810 |
Why?
|
| Memory, Short-Term | 2 | 2021 | 142 | 0.810 |
Why?
|
| Parturition | 1 | 2024 | 66 | 0.810 |
Why?
|
| Video Recording | 1 | 2025 | 204 | 0.810 |
Why?
|
| Clergy | 1 | 2023 | 5 | 0.800 |
Why?
|
| Social Support | 8 | 2025 | 386 | 0.800 |
Why?
|
| Attitude to Health | 10 | 2017 | 260 | 0.790 |
Why?
|
| Religion and Psychology | 4 | 2023 | 33 | 0.790 |
Why?
|
| Drug Prescriptions | 4 | 2018 | 238 | 0.790 |
Why?
|
| Body Dysmorphic Disorders | 2 | 2014 | 17 | 0.780 |
Why?
|
| Clinical Competence | 3 | 2022 | 1071 | 0.780 |
Why?
|
| Pilot Projects | 16 | 2020 | 1454 | 0.770 |
Why?
|
| Religion | 4 | 2004 | 51 | 0.770 |
Why?
|
| Internal-External Control | 11 | 2019 | 75 | 0.760 |
Why?
|
| Feeding and Eating Disorders | 3 | 2020 | 76 | 0.750 |
Why?
|
| Patient Selection | 3 | 2024 | 730 | 0.740 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2023 | 897 | 0.740 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2016 | 149 | 0.740 |
Why?
|
| Psychotherapy, Brief | 2 | 2013 | 57 | 0.730 |
Why?
|
| Perfectionism | 1 | 2021 | 1 | 0.730 |
Why?
|
| Pain Management | 1 | 2024 | 199 | 0.720 |
Why?
|
| Impulsive Behavior | 6 | 2025 | 159 | 0.720 |
Why?
|
| Faculty | 2 | 2021 | 104 | 0.720 |
Why?
|
| Behavior Observation Techniques | 3 | 2019 | 5 | 0.710 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 72 | 0.700 |
Why?
|
| Patient Compliance | 12 | 2019 | 475 | 0.700 |
Why?
|
| Child Health | 1 | 2022 | 69 | 0.690 |
Why?
|
| Health Behavior | 4 | 2020 | 399 | 0.690 |
Why?
|
| Fractures, Bone | 1 | 2023 | 206 | 0.690 |
Why?
|
| Tics | 6 | 2020 | 49 | 0.680 |
Why?
|
| Substance-Related Disorders | 2 | 2024 | 491 | 0.680 |
Why?
|
| Treatment Refusal | 2 | 2020 | 80 | 0.680 |
Why?
|
| Cannabis | 2 | 2020 | 50 | 0.680 |
Why?
|
| Politics | 2 | 2018 | 61 | 0.680 |
Why?
|
| Cost-Benefit Analysis | 7 | 2025 | 557 | 0.670 |
Why?
|
| Motivational Interviewing | 1 | 2021 | 48 | 0.670 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2022 | 138 | 0.660 |
Why?
|
| Universities | 7 | 2020 | 129 | 0.660 |
Why?
|
| Residential Treatment | 5 | 2019 | 13 | 0.660 |
Why?
|
| Disasters | 2 | 2018 | 105 | 0.660 |
Why?
|
| Drug Utilization | 2 | 2019 | 165 | 0.650 |
Why?
|
| Sex Factors | 13 | 2024 | 1353 | 0.640 |
Why?
|
| Patient Dropouts | 1 | 2019 | 52 | 0.630 |
Why?
|
| Cost of Illness | 3 | 2017 | 275 | 0.620 |
Why?
|
| Sports | 4 | 2004 | 66 | 0.620 |
Why?
|
| Prader-Willi Syndrome | 3 | 2015 | 71 | 0.620 |
Why?
|
| Models, Psychological | 8 | 2020 | 144 | 0.610 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2023 | 104 | 0.600 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2016 | 23 | 0.600 |
Why?
|
| Medicaid | 2 | 2019 | 247 | 0.600 |
Why?
|
| Dissociative Disorders | 2 | 2019 | 12 | 0.590 |
Why?
|
| Community Mental Health Centers | 2 | 2015 | 8 | 0.590 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 30 | 0.570 |
Why?
|
| School Health Services | 4 | 2007 | 102 | 0.570 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 2 | 2016 | 34 | 0.560 |
Why?
|
| Analysis of Variance | 11 | 2014 | 1009 | 0.560 |
Why?
|
| Self Concept | 7 | 2023 | 164 | 0.560 |
Why?
|
| Expressed Emotion | 2 | 2015 | 9 | 0.550 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2024 | 1247 | 0.550 |
Why?
|
| Antimetabolites | 2 | 2018 | 30 | 0.550 |
Why?
|
| Florida | 11 | 2019 | 80 | 0.550 |
Why?
|
| Lyme Disease | 1 | 2018 | 37 | 0.540 |
Why?
|
| Clomipramine | 2 | 2014 | 16 | 0.540 |
Why?
|
| Marijuana Use | 1 | 2017 | 14 | 0.540 |
Why?
|
| Decision Making | 2 | 2021 | 693 | 0.540 |
Why?
|
| Spain | 4 | 2025 | 65 | 0.530 |
Why?
|
| Behavior Rating Scale | 1 | 2017 | 6 | 0.530 |
Why?
|
| Psychotherapy, Group | 5 | 2021 | 59 | 0.530 |
Why?
|
| Postpartum Period | 4 | 2025 | 231 | 0.520 |
Why?
|
| Anticipation, Psychological | 1 | 2016 | 6 | 0.520 |
Why?
|
| Streptococcus pyogenes | 5 | 2013 | 79 | 0.520 |
Why?
|
| Double-Blind Method | 10 | 2020 | 1648 | 0.510 |
Why?
|
| Hallucinogens | 1 | 2017 | 51 | 0.500 |
Why?
|
| Outpatients | 5 | 2023 | 275 | 0.500 |
Why?
|
| Paraphilic Disorders | 1 | 2016 | 4 | 0.500 |
Why?
|
| Self Care | 8 | 2011 | 227 | 0.500 |
Why?
|
| Length of Stay | 2 | 2019 | 1378 | 0.500 |
Why?
|
| Students, Medical | 1 | 2021 | 362 | 0.500 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 2303 | 0.500 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 551 | 0.490 |
Why?
|
| Dystonia | 3 | 2023 | 173 | 0.480 |
Why?
|
| Patient Satisfaction | 2 | 2023 | 483 | 0.480 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2016 | 98 | 0.470 |
Why?
|
| Compulsive Personality Disorder | 5 | 2023 | 16 | 0.470 |
Why?
|
| Drug Therapy, Combination | 8 | 2020 | 1163 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 5 | 2024 | 1305 | 0.460 |
Why?
|
| Drug Resistance | 3 | 2013 | 252 | 0.460 |
Why?
|
| Activities of Daily Living | 6 | 2011 | 428 | 0.460 |
Why?
|
| Cyclohexanols | 1 | 2014 | 8 | 0.450 |
Why?
|
| Helplessness, Learned | 1 | 2014 | 8 | 0.450 |
Why?
|
| Professional-Patient Relations | 2 | 2016 | 92 | 0.450 |
Why?
|
| Psychosocial Deprivation | 2 | 2004 | 5 | 0.450 |
Why?
|
| Aged, 80 and over | 12 | 2025 | 7111 | 0.450 |
Why?
|
| Adult Children | 1 | 2014 | 6 | 0.450 |
Why?
|
| Nursing Assessment | 3 | 2011 | 24 | 0.440 |
Why?
|
| Child of Impaired Parents | 1 | 2014 | 18 | 0.440 |
Why?
|
| Prevalence | 13 | 2025 | 2665 | 0.440 |
Why?
|
| Body Weight | 2 | 2016 | 1006 | 0.430 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1161 | 0.430 |
Why?
|
| Sensation Disorders | 1 | 2014 | 24 | 0.430 |
Why?
|
| Prefrontal Cortex | 4 | 2025 | 218 | 0.430 |
Why?
|
| Adolescent Psychiatry | 5 | 2024 | 15 | 0.430 |
Why?
|
| Child Abuse | 2 | 2018 | 204 | 0.430 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 97 | 0.430 |
Why?
|
| Puerperal Disorders | 1 | 2014 | 47 | 0.430 |
Why?
|
| Psychotherapy, Psychodynamic | 1 | 2013 | 2 | 0.420 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 180 | 0.420 |
Why?
|
| Sensitivity and Specificity | 10 | 2024 | 2145 | 0.420 |
Why?
|
| Ambulatory Care | 1 | 2017 | 412 | 0.420 |
Why?
|
| Schizencephaly | 1 | 2013 | 1 | 0.410 |
Why?
|
| Judgment | 2 | 2010 | 38 | 0.410 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 242 | 0.410 |
Why?
|
| Social Identification | 2 | 2025 | 20 | 0.410 |
Why?
|
| Motivation | 6 | 2021 | 329 | 0.410 |
Why?
|
| Isoxazoles | 1 | 2013 | 24 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 4 | 2024 | 2557 | 0.410 |
Why?
|
| Attitude to Computers | 1 | 2013 | 48 | 0.400 |
Why?
|
| Developmental Disabilities | 2 | 2016 | 749 | 0.400 |
Why?
|
| Aging | 1 | 2020 | 1261 | 0.400 |
Why?
|
| Statistics as Topic | 5 | 2017 | 254 | 0.400 |
Why?
|
| Septal Nuclei | 2 | 2023 | 14 | 0.400 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 72 | 0.400 |
Why?
|
| Disability Evaluation | 2 | 2016 | 194 | 0.390 |
Why?
|
| Obesity | 4 | 2010 | 2406 | 0.390 |
Why?
|
| Uncertainty | 3 | 2023 | 103 | 0.390 |
Why?
|
| Negotiating | 1 | 2012 | 12 | 0.390 |
Why?
|
| Astrocytoma | 1 | 2013 | 111 | 0.390 |
Why?
|
| Medication Adherence | 1 | 2016 | 326 | 0.390 |
Why?
|
| Social Perception | 3 | 2020 | 56 | 0.390 |
Why?
|
| Dizziness | 1 | 2012 | 27 | 0.390 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2014 | 128 | 0.380 |
Why?
|
| Academic Performance | 2 | 2025 | 25 | 0.380 |
Why?
|
| Breast Feeding | 1 | 2014 | 240 | 0.380 |
Why?
|
| Syndrome | 5 | 2022 | 1171 | 0.370 |
Why?
|
| Brain | 6 | 2023 | 3198 | 0.370 |
Why?
|
| Respiratory Sinus Arrhythmia | 3 | 2020 | 10 | 0.370 |
Why?
|
| Patient Care Team | 1 | 2016 | 572 | 0.370 |
Why?
|
| Treatment Failure | 5 | 2020 | 364 | 0.360 |
Why?
|
| Retrospective Studies | 10 | 2024 | 17364 | 0.360 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 348 | 0.360 |
Why?
|
| Social Stigma | 3 | 2023 | 85 | 0.360 |
Why?
|
| Personality | 2 | 2014 | 114 | 0.360 |
Why?
|
| Overweight | 3 | 2015 | 384 | 0.360 |
Why?
|
| Social Media | 2 | 2025 | 121 | 0.360 |
Why?
|
| Memory | 2 | 2014 | 355 | 0.360 |
Why?
|
| Dystonic Disorders | 2 | 2023 | 94 | 0.350 |
Why?
|
| Ventral Striatum | 4 | 2025 | 43 | 0.350 |
Why?
|
| Benchmarking | 2 | 2025 | 137 | 0.350 |
Why?
|
| Quinolones | 2 | 2009 | 58 | 0.350 |
Why?
|
| Problem Behavior | 3 | 2023 | 41 | 0.350 |
Why?
|
| Psychology, Adolescent | 4 | 2008 | 35 | 0.350 |
Why?
|
| Community Participation | 1 | 2011 | 42 | 0.350 |
Why?
|
| Tremor | 1 | 2012 | 136 | 0.350 |
Why?
|
| Incidence | 6 | 2019 | 3362 | 0.350 |
Why?
|
| Endocrine System Diseases | 3 | 2008 | 43 | 0.340 |
Why?
|
| Desensitization, Psychologic | 4 | 2016 | 6 | 0.340 |
Why?
|
| Psychology, Child | 6 | 2008 | 44 | 0.340 |
Why?
|
| Observer Variation | 6 | 2023 | 307 | 0.340 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 761 | 0.340 |
Why?
|
| Smoking | 1 | 2016 | 942 | 0.340 |
Why?
|
| Bullying | 1 | 2010 | 18 | 0.340 |
Why?
|
| Perception | 4 | 2021 | 237 | 0.340 |
Why?
|
| Louisiana | 3 | 2018 | 135 | 0.340 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2010 | 13 | 0.320 |
Why?
|
| Follow-Up Studies | 9 | 2016 | 5405 | 0.320 |
Why?
|
| Pyrimidines | 1 | 2013 | 419 | 0.320 |
Why?
|
| Occupations | 1 | 2009 | 20 | 0.320 |
Why?
|
| Neurosciences | 2 | 2021 | 52 | 0.320 |
Why?
|
| Latin America | 3 | 2025 | 99 | 0.320 |
Why?
|
| Panic Disorder | 1 | 2010 | 52 | 0.310 |
Why?
|
| Motor Activity | 3 | 2018 | 521 | 0.310 |
Why?
|
| Chronic Disease | 7 | 2016 | 1229 | 0.310 |
Why?
|
| Bezoars | 1 | 2009 | 5 | 0.310 |
Why?
|
| Piperazines | 2 | 2009 | 254 | 0.310 |
Why?
|
| Pregnancy | 8 | 2025 | 7567 | 0.310 |
Why?
|
| Habits | 3 | 2019 | 25 | 0.310 |
Why?
|
| Empirical Research | 2 | 2009 | 9 | 0.310 |
Why?
|
| Remission Induction | 4 | 2024 | 307 | 0.300 |
Why?
|
| Case-Control Studies | 9 | 2025 | 3422 | 0.300 |
Why?
|
| Primary Health Care | 1 | 2015 | 800 | 0.300 |
Why?
|
| Emergency Shelter | 2 | 2019 | 9 | 0.290 |
Why?
|
| Bioethics | 2 | 2020 | 74 | 0.290 |
Why?
|
| Health Surveys | 3 | 2023 | 259 | 0.290 |
Why?
|
| Internationality | 2 | 2020 | 133 | 0.290 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 10 | 0.290 |
Why?
|
| Conduct Disorder | 2 | 2020 | 32 | 0.280 |
Why?
|
| Mental Recall | 3 | 2019 | 144 | 0.280 |
Why?
|
| Nerve Net | 2 | 2021 | 264 | 0.270 |
Why?
|
| Risk Factors | 13 | 2023 | 10911 | 0.270 |
Why?
|
| Time Factors | 6 | 2017 | 6456 | 0.260 |
Why?
|
| Body Height | 2 | 2005 | 227 | 0.260 |
Why?
|
| Bipolar Disorder | 2 | 2021 | 369 | 0.260 |
Why?
|
| Health Status | 2 | 2009 | 409 | 0.260 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.260 |
Why?
|
| Behavior | 1 | 2006 | 74 | 0.260 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 680 | 0.250 |
Why?
|
| Minority Groups | 4 | 2021 | 250 | 0.250 |
Why?
|
| Problem Solving | 3 | 2018 | 68 | 0.250 |
Why?
|
| Psychology | 3 | 2016 | 58 | 0.240 |
Why?
|
| Fluoxetine | 1 | 2006 | 44 | 0.240 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 2062 | 0.240 |
Why?
|
| New York City | 2 | 2022 | 65 | 0.240 |
Why?
|
| Affect | 5 | 2020 | 173 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1672 | 0.240 |
Why?
|
| Beta Rhythm | 1 | 2025 | 28 | 0.230 |
Why?
|
| Stereotyping | 2 | 2023 | 20 | 0.230 |
Why?
|
| Attention | 4 | 2020 | 200 | 0.230 |
Why?
|
| ROC Curve | 3 | 2025 | 598 | 0.230 |
Why?
|
| Canada | 3 | 2021 | 343 | 0.230 |
Why?
|
| Health Care Costs | 2 | 2022 | 407 | 0.230 |
Why?
|
| Bias | 3 | 2020 | 144 | 0.230 |
Why?
|
| Anorexia Nervosa | 2 | 2017 | 29 | 0.220 |
Why?
|
| Morals | 2 | 2022 | 73 | 0.220 |
Why?
|
| Feasibility Studies | 3 | 2021 | 826 | 0.220 |
Why?
|
| Southeastern United States | 4 | 2011 | 36 | 0.220 |
Why?
|
| Gynecomastia | 1 | 2004 | 6 | 0.220 |
Why?
|
| Symptom Assessment | 5 | 2019 | 109 | 0.220 |
Why?
|
| Prognosis | 8 | 2018 | 5010 | 0.220 |
Why?
|
| Regression Analysis | 3 | 2019 | 801 | 0.220 |
Why?
|
| Education | 3 | 2010 | 111 | 0.220 |
Why?
|
| Linguistics | 1 | 2024 | 19 | 0.220 |
Why?
|
| Asperger Syndrome | 2 | 2014 | 7 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2004 | 98 | 0.210 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2004 | 36 | 0.210 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 1409 | 0.210 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2024 | 150 | 0.210 |
Why?
|
| Public Opinion | 2 | 2022 | 62 | 0.210 |
Why?
|
| Ceremonial Behavior | 1 | 2023 | 5 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2025 | 150 | 0.210 |
Why?
|
| Clinical Trials as Topic | 4 | 2020 | 1153 | 0.210 |
Why?
|
| Computers | 1 | 2023 | 70 | 0.210 |
Why?
|
| Genetic Loci | 1 | 2025 | 362 | 0.200 |
Why?
|
| Autoantibodies | 1 | 2006 | 459 | 0.200 |
Why?
|
| Consensus | 2 | 2020 | 656 | 0.200 |
Why?
|
| Social Values | 1 | 2003 | 48 | 0.200 |
Why?
|
| Growth Disorders | 1 | 2005 | 227 | 0.200 |
Why?
|
| Cognitive Dissonance | 1 | 2003 | 3 | 0.200 |
Why?
|
| Culturally Competent Care | 1 | 2024 | 52 | 0.200 |
Why?
|
| Pediatrics | 3 | 2021 | 1215 | 0.200 |
Why?
|
| Ethics | 1 | 2003 | 23 | 0.200 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 167 | 0.200 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 1831 | 0.200 |
Why?
|
| Deception | 1 | 2003 | 11 | 0.200 |
Why?
|
| Self Efficacy | 1 | 2024 | 209 | 0.200 |
Why?
|
| Cultural Competency | 1 | 2024 | 52 | 0.200 |
Why?
|
| Physicians | 1 | 2010 | 635 | 0.200 |
Why?
|
| Pessimism | 1 | 2022 | 4 | 0.200 |
Why?
|
| Brazil | 3 | 2023 | 138 | 0.200 |
Why?
|
| Informed Consent | 2 | 2023 | 346 | 0.200 |
Why?
|
| Checklist | 2 | 2022 | 96 | 0.200 |
Why?
|
| Psychological Theory | 1 | 2003 | 37 | 0.200 |
Why?
|
| Thinking | 1 | 2022 | 34 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3358 | 0.190 |
Why?
|
| Fatigue | 1 | 2023 | 198 | 0.190 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 922 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 305 | 0.190 |
Why?
|
| Mothers | 3 | 2021 | 374 | 0.190 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2025 | 128 | 0.190 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 901 | 0.190 |
Why?
|
| Internal Capsule | 4 | 2023 | 51 | 0.190 |
Why?
|
| Sexual Behavior | 3 | 2023 | 250 | 0.190 |
Why?
|
| Pharmacogenetics | 1 | 2023 | 200 | 0.190 |
Why?
|
| Morbidity | 1 | 2022 | 255 | 0.190 |
Why?
|
| Quarantine | 1 | 2021 | 17 | 0.180 |
Why?
|
| Games, Recreational | 1 | 2021 | 11 | 0.180 |
Why?
|
| Self-Assessment | 4 | 2009 | 65 | 0.180 |
Why?
|
| Off-Label Use | 1 | 2021 | 29 | 0.180 |
Why?
|
| El Salvador | 2 | 2020 | 4 | 0.180 |
Why?
|
| Capital Financing | 1 | 2021 | 7 | 0.180 |
Why?
|
| Social Environment | 2 | 2014 | 122 | 0.180 |
Why?
|
| Character | 1 | 2001 | 4 | 0.180 |
Why?
|
| Interdisciplinary Research | 1 | 2021 | 10 | 0.180 |
Why?
|
| Critical Care | 1 | 2007 | 687 | 0.180 |
Why?
|
| Electrophysiology | 1 | 2021 | 269 | 0.180 |
Why?
|
| Actuarial Analysis | 1 | 2020 | 30 | 0.170 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 253 | 0.170 |
Why?
|
| Alcohol Drinking in College | 1 | 2020 | 8 | 0.170 |
Why?
|
| Connectome | 1 | 2023 | 122 | 0.170 |
Why?
|
| Knowledge | 1 | 2021 | 51 | 0.170 |
Why?
|
| Logistic Models | 4 | 2018 | 1840 | 0.170 |
Why?
|
| Symptom Flare Up | 1 | 2020 | 24 | 0.170 |
Why?
|
| Pain | 1 | 2023 | 461 | 0.170 |
Why?
|
| Infant | 4 | 2022 | 13195 | 0.170 |
Why?
|
| Socialization | 1 | 2020 | 17 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 20 | 0.170 |
Why?
|
| Single-Blind Method | 2 | 2014 | 247 | 0.170 |
Why?
|
| Yoga | 1 | 2020 | 13 | 0.170 |
Why?
|
| Aerospace Medicine | 1 | 2020 | 39 | 0.160 |
Why?
|
| Parasympathetic Nervous System | 1 | 2020 | 15 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 87 | 0.160 |
Why?
|
| Meditation | 1 | 2020 | 20 | 0.160 |
Why?
|
| United Kingdom | 1 | 2020 | 234 | 0.160 |
Why?
|
| Public Health | 1 | 2022 | 282 | 0.160 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 59 | 0.160 |
Why?
|
| Child Abuse, Sexual | 1 | 2020 | 34 | 0.160 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2010 | 12 | 0.160 |
Why?
|
| Health Literacy | 1 | 2021 | 78 | 0.160 |
Why?
|
| Occupational Stress | 1 | 2020 | 13 | 0.160 |
Why?
|
| Vagus Nerve | 1 | 2019 | 46 | 0.160 |
Why?
|
| Phenotype | 2 | 2023 | 4545 | 0.160 |
Why?
|
| Models, Theoretical | 2 | 2015 | 392 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2021 | 108 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 332 | 0.150 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 156 | 0.150 |
Why?
|
| Psychological Techniques | 1 | 2019 | 8 | 0.150 |
Why?
|
| Hospitals, Teaching | 1 | 2019 | 113 | 0.150 |
Why?
|
| Weightlessness | 1 | 2020 | 80 | 0.150 |
Why?
|
| Culture | 2 | 2009 | 72 | 0.150 |
Why?
|
| Chorea | 2 | 2011 | 39 | 0.150 |
Why?
|
| Age of Onset | 3 | 2009 | 626 | 0.150 |
Why?
|
| Friends | 1 | 2018 | 18 | 0.150 |
Why?
|
| Genomics | 2 | 2025 | 1652 | 0.150 |
Why?
|
| Conditioning, Classical | 1 | 2019 | 54 | 0.150 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 20 | 0.150 |
Why?
|
| Delphi Technique | 1 | 2020 | 240 | 0.150 |
Why?
|
| Patient Education as Topic | 2 | 2021 | 460 | 0.150 |
Why?
|
| Mass Screening | 1 | 2024 | 831 | 0.150 |
Why?
|
| Longitudinal Studies | 5 | 2025 | 1502 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2019 | 110 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2020 | 406 | 0.150 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 144 | 0.140 |
Why?
|
| Cognition Disorders | 2 | 2014 | 571 | 0.140 |
Why?
|
| Civil Defense | 1 | 2018 | 7 | 0.140 |
Why?
|
| Contraception | 1 | 2018 | 61 | 0.140 |
Why?
|
| Nail Biting | 1 | 2017 | 4 | 0.140 |
Why?
|
| Communication | 1 | 2022 | 540 | 0.140 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2018 | 23 | 0.140 |
Why?
|
| Prospective Studies | 8 | 2025 | 6540 | 0.140 |
Why?
|
| Health Promotion | 1 | 2021 | 404 | 0.140 |
Why?
|
| Nurse's Role | 2 | 2008 | 41 | 0.140 |
Why?
|
| Ethics, Medical | 1 | 2020 | 401 | 0.140 |
Why?
|
| Diagnosis, Differential | 6 | 2014 | 1964 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2017 | 19 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2000 | 332 | 0.130 |
Why?
|
| N-Methylaspartate | 1 | 2017 | 28 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2018 | 107 | 0.130 |
Why?
|
| Translations | 1 | 2017 | 18 | 0.130 |
Why?
|
| Social Isolation | 1 | 2017 | 47 | 0.130 |
Why?
|
| Reversal Learning | 1 | 2016 | 7 | 0.130 |
Why?
|
| Space Flight | 1 | 2020 | 170 | 0.130 |
Why?
|
| Azithromycin | 1 | 2017 | 44 | 0.130 |
Why?
|
| Poverty | 1 | 2020 | 437 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 278 | 0.130 |
Why?
|
| Acute Disease | 4 | 2017 | 1176 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2015 | 1707 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2019 | 418 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2022 | 8568 | 0.120 |
Why?
|
| Health Care Surveys | 1 | 2017 | 292 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 447 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 85 | 0.120 |
Why?
|
| Psychopathology | 1 | 2015 | 34 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2022 | 3710 | 0.120 |
Why?
|
| Survivors | 1 | 2018 | 359 | 0.120 |
Why?
|
| Sex Distribution | 2 | 2007 | 324 | 0.110 |
Why?
|
| Intelligence | 1 | 2015 | 108 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2018 | 1256 | 0.110 |
Why?
|
| Patient Safety | 1 | 2019 | 437 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 585 | 0.110 |
Why?
|
| Age Distribution | 2 | 2007 | 433 | 0.110 |
Why?
|
| Actigraphy | 1 | 2014 | 47 | 0.110 |
Why?
|
| Yohimbine | 1 | 2014 | 17 | 0.110 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2014 | 15 | 0.110 |
Why?
|
| Sense of Coherence | 1 | 2014 | 3 | 0.110 |
Why?
|
| Music | 1 | 2014 | 17 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2014 | 77 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 171 | 0.110 |
Why?
|
| Cephalosporins | 1 | 2014 | 141 | 0.100 |
Why?
|
| Linear Models | 3 | 2010 | 713 | 0.100 |
Why?
|
| Paliperidone Palmitate | 1 | 2013 | 4 | 0.100 |
Why?
|
| Stroke | 1 | 2022 | 1068 | 0.100 |
Why?
|
| Education, Nursing, Continuing | 1 | 2013 | 18 | 0.100 |
Why?
|
| Patient Participation | 1 | 2016 | 240 | 0.100 |
Why?
|
| Recurrence | 2 | 2014 | 1458 | 0.100 |
Why?
|
| Sex Characteristics | 2 | 2012 | 330 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 471 | 0.100 |
Why?
|
| Psychophysiology | 1 | 2012 | 9 | 0.100 |
Why?
|
| Child, Institutionalized | 1 | 2012 | 7 | 0.100 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2011 | 124 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 3853 | 0.100 |
Why?
|
| Hyperkinesis | 1 | 2012 | 27 | 0.100 |
Why?
|
| Psychomotor Agitation | 1 | 2012 | 57 | 0.100 |
Why?
|
| Betacoronavirus | 3 | 2020 | 300 | 0.100 |
Why?
|
| Focus Groups | 1 | 2013 | 215 | 0.100 |
Why?
|
| Veterans | 1 | 2024 | 1762 | 0.090 |
Why?
|
| Helping Behavior | 1 | 2012 | 6 | 0.090 |
Why?
|
| Aripiprazole | 2 | 2009 | 22 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2011 | 569 | 0.090 |
Why?
|
| Empathy | 1 | 2012 | 64 | 0.090 |
Why?
|
| Pinealoma | 1 | 2011 | 23 | 0.090 |
Why?
|
| Germinoma | 1 | 2011 | 32 | 0.090 |
Why?
|
| Self-Help Groups | 1 | 2011 | 16 | 0.090 |
Why?
|
| Globus Pallidus | 2 | 2021 | 69 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 1443 | 0.090 |
Why?
|
| School Nursing | 1 | 2011 | 9 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2011 | 96 | 0.090 |
Why?
|
| Self Mutilation | 1 | 2010 | 5 | 0.090 |
Why?
|
| Agonistic Behavior | 2 | 2007 | 8 | 0.080 |
Why?
|
| Body Image | 1 | 2010 | 43 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2386 | 0.080 |
Why?
|
| Avoidance Learning | 2 | 2014 | 60 | 0.080 |
Why?
|
| Serotonin Agents | 1 | 2009 | 15 | 0.080 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 411 | 0.080 |
Why?
|
| Risk-Taking | 1 | 2010 | 101 | 0.080 |
Why?
|
| Propylamines | 1 | 2009 | 8 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2023 | 375 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2009 | 29 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 197 | 0.070 |
Why?
|
| Risperidone | 1 | 2009 | 59 | 0.070 |
Why?
|
| Defense Mechanisms | 2 | 2019 | 12 | 0.070 |
Why?
|
| Neurobiology | 1 | 2008 | 26 | 0.070 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2009 | 148 | 0.070 |
Why?
|
| Psychiatric Nursing | 1 | 2007 | 8 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2008 | 130 | 0.070 |
Why?
|
| Reference Values | 2 | 2010 | 721 | 0.070 |
Why?
|
| Language | 2 | 2019 | 225 | 0.070 |
Why?
|
| Registries | 2 | 2025 | 1585 | 0.070 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2007 | 15 | 0.070 |
Why?
|
| Placebos | 1 | 2007 | 232 | 0.060 |
Why?
|
| Retreatment | 1 | 2007 | 92 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2008 | 175 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2009 | 284 | 0.060 |
Why?
|
| Directive Counseling | 1 | 2006 | 24 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 159 | 0.060 |
Why?
|
| Achievement | 1 | 2006 | 32 | 0.060 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 10 | 0.060 |
Why?
|
| Telephone | 1 | 2006 | 126 | 0.060 |
Why?
|
| Family Practice | 1 | 2006 | 89 | 0.060 |
Why?
|
| Scandinavian and Nordic Countries | 1 | 2025 | 4 | 0.060 |
Why?
|
| Research Design | 2 | 2021 | 750 | 0.060 |
Why?
|
| Caribbean Region | 1 | 2025 | 20 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 482 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2005 | 31 | 0.060 |
Why?
|
| Indonesia | 1 | 2025 | 21 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2023 | 1098 | 0.060 |
Why?
|
| Nuclear Family | 1 | 2005 | 51 | 0.060 |
Why?
|
| Speech | 1 | 2025 | 79 | 0.060 |
Why?
|
| Growth | 1 | 2005 | 102 | 0.060 |
Why?
|
| Social Alienation | 1 | 2004 | 2 | 0.060 |
Why?
|
| North America | 1 | 2025 | 265 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2025 | 102 | 0.060 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 54 | 0.060 |
Why?
|
| Bacteriocins | 1 | 2004 | 6 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 327 | 0.050 |
Why?
|
| Periodicity | 1 | 2024 | 51 | 0.050 |
Why?
|
| Hemolysin Proteins | 1 | 2004 | 30 | 0.050 |
Why?
|
| Nursing Methodology Research | 3 | 2008 | 14 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 748 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2004 | 43 | 0.050 |
Why?
|
| Patient Health Questionnaire | 1 | 2023 | 16 | 0.050 |
Why?
|
| Social Desirability | 1 | 2004 | 18 | 0.050 |
Why?
|
| Anhedonia | 1 | 2024 | 36 | 0.050 |
Why?
|
| Insulin | 2 | 2006 | 1211 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2004 | 105 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2004 | 176 | 0.050 |
Why?
|
| Competitive Behavior | 1 | 2002 | 11 | 0.050 |
Why?
|
| Counseling | 1 | 2005 | 235 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2024 | 436 | 0.050 |
Why?
|
| Urban Population | 1 | 2004 | 245 | 0.050 |
Why?
|
| Thalamus | 1 | 2023 | 88 | 0.050 |
Why?
|
| Disease Management | 1 | 2006 | 565 | 0.050 |
Why?
|
| Microcirculation | 1 | 2022 | 117 | 0.050 |
Why?
|
| Philosophy, Medical | 1 | 2021 | 19 | 0.050 |
Why?
|
| Electrodes | 1 | 2021 | 91 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 295 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2025 | 311 | 0.040 |
Why?
|
| Organizations | 1 | 2001 | 16 | 0.040 |
Why?
|
| Self Disclosure | 1 | 2001 | 26 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2022 | 351 | 0.040 |
Why?
|
| Streptococcus | 2 | 2011 | 63 | 0.040 |
Why?
|
| Iran | 1 | 2021 | 96 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2000 | 63 | 0.040 |
Why?
|
| Sensation | 1 | 2020 | 51 | 0.040 |
Why?
|
| Functional Neuroimaging | 1 | 2020 | 35 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 847 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 309 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 37 | 0.040 |
Why?
|
| Chile | 1 | 2020 | 25 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2000 | 143 | 0.040 |
Why?
|
| Catastrophization | 1 | 2020 | 18 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 133 | 0.040 |
Why?
|
| Technology | 1 | 2020 | 69 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 130 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 370 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2019 | 27 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2019 | 7 | 0.040 |
Why?
|
| Wakefulness | 1 | 2020 | 105 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 148 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2021 | 281 | 0.040 |
Why?
|
| Maryland | 1 | 1998 | 34 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2000 | 292 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 448 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 359 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2025 | 1583 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 1451 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5150 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 373 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 2018 | 54 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 679 | 0.030 |
Why?
|
| Heart Rate | 1 | 2020 | 573 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2018 | 54 | 0.030 |
Why?
|
| Sleep | 1 | 2020 | 370 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 234 | 0.030 |
Why?
|
| Software | 1 | 2021 | 729 | 0.030 |
Why?
|
| Atrial Function | 1 | 1996 | 14 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 179 | 0.030 |
Why?
|
| Women | 1 | 1996 | 18 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 59 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2851 | 0.030 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2015 | 12 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2016 | 56 | 0.030 |
Why?
|
| Menopause | 1 | 1996 | 90 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2021 | 553 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1996 | 130 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 254 | 0.030 |
Why?
|
| Hippocampus | 1 | 2020 | 819 | 0.030 |
Why?
|
| Imagination | 1 | 2014 | 18 | 0.030 |
Why?
|
| Hallucinations | 1 | 2014 | 28 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 865 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2014 | 71 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 341 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2015 | 494 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 34995 | 0.020 |
Why?
|
| Adenoidectomy | 1 | 2013 | 84 | 0.020 |
Why?
|
| Schools | 1 | 2014 | 238 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 316 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3391 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2018 | 698 | 0.020 |
Why?
|
| Tonsillectomy | 1 | 2013 | 109 | 0.020 |
Why?
|
| Postnatal Care | 1 | 2011 | 52 | 0.020 |
Why?
|
| Antistreptolysin | 1 | 2011 | 2 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 406 | 0.020 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2009 | 15 | 0.020 |
Why?
|
| Social Class | 1 | 2010 | 207 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 763 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2010 | 236 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2008 | 120 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 42 | 0.020 |
Why?
|
| Health Education | 1 | 2009 | 232 | 0.020 |
Why?
|
| Weight Gain | 1 | 2010 | 408 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 389 | 0.020 |
Why?
|
| Pharynx | 1 | 2006 | 67 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 198 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2006 | 202 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 230 | 0.010 |
Why?
|
| Seasons | 1 | 2006 | 331 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1171 | 0.010 |
Why?
|
| Personality Disorders | 1 | 2007 | 169 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2004 | 87 | 0.010 |
Why?
|
| New York | 1 | 2001 | 72 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 440 | 0.010 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 1996 | 20 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1996 | 24 | 0.010 |
Why?
|
| Free Radicals | 1 | 1996 | 33 | 0.010 |
Why?
|
| Uruguay | 1 | 1996 | 15 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1996 | 77 | 0.010 |
Why?
|
| Bereavement | 1 | 1996 | 21 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1996 | 154 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 448 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1996 | 80 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1996 | 149 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1996 | 867 | 0.010 |
Why?
|
| Gynecology | 1 | 1996 | 129 | 0.010 |
Why?
|
| Action Potentials | 1 | 1996 | 489 | 0.010 |
Why?
|
| Life Style | 1 | 1996 | 455 | 0.010 |
Why?
|